Educating Rheumatology Staff Quadrupled Medical Cannabis Referrals for Fibromyalgia Patients

An educational intervention about medical cannabis benefits for fibromyalgia increased referral rates from 4% to 17% in a rheumatology clinic, a statistically significant change.

McClure, Linh M et al.·Journal of holistic nursing : official journal of the American Holistic Nurses' Association·2025·Preliminary EvidenceObservational
RTHC-07098ObservationalPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Following an educational intervention on the benefits of medical cannabis for fibromyalgia, medical cannabis referrals increased from 4% to 17% of eligible patients (Z-score 2.3143, p = 0.0103).

Key Numbers

Pre-intervention: 4% referral rate. Post-intervention: 17% referral rate. Z-score: 2.3143. P-value: 0.0103.

How They Did This

Quality improvement project in a single rheumatology clinic. An educational intervention on medical cannabis benefits for fibromyalgia was implemented for clinic staff. Pre- and post-intervention referral rates were compared.

Why This Research Matters

Polypharmacy is a significant problem in fibromyalgia management. If medical cannabis can replace some conventional medications, provider education about this option could improve holistic patient care. The dramatic increase in referrals suggests that many providers simply were not aware of the option.

The Bigger Picture

Provider education appears to be a major bottleneck for medical cannabis access. If a simple educational intervention can quadruple referral rates, similar programs could substantially increase patient access across other specialties.

What This Study Doesn't Tell Us

Single clinic quality improvement project. No control group. Short follow-up period. Increased referrals do not necessarily mean improved patient outcomes. The educational content may have been advocacy-oriented rather than balanced.

Questions This Raises

  • ?Do the referred patients actually benefit from medical cannabis?
  • ?Would similar educational interventions work in other specialties?

Trust & Context

Key Stat:
Referral rate increased from 4% to 17% after education
Evidence Grade:
Single-site quality improvement project without a control group. Demonstrates feasibility but not effectiveness of the referrals themselves.
Study Age:
Published in 2025.
Original Title:
Improving Awareness and Use of Medical Cannabis for Fibromyalgia.
Published In:
Journal of holistic nursing : official journal of the American Holistic Nurses' Association, 8980101251376863 (2025)
Database ID:
RTHC-07098

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Does medical cannabis help fibromyalgia?

Some evidence suggests it may help with pain, sleep, and quality of life in fibromyalgia. This study focused on increasing referrals rather than measuring patient outcomes from cannabis use.

Why were referral rates so low before the intervention?

The 4% pre-intervention rate likely reflects lack of provider awareness, comfort, or education about medical cannabis as a treatment option for fibromyalgia.

Read More on RethinkTHC

Cite This Study

RTHC-07098·https://rethinkthc.com/research/RTHC-07098

APA

McClure, Linh M; West, Gordon F. (2025). Improving Awareness and Use of Medical Cannabis for Fibromyalgia.. Journal of holistic nursing : official journal of the American Holistic Nurses' Association, 8980101251376863. https://doi.org/10.1177/08980101251376863

MLA

McClure, Linh M, et al. "Improving Awareness and Use of Medical Cannabis for Fibromyalgia.." Journal of holistic nursing : official journal of the American Holistic Nurses' Association, 2025. https://doi.org/10.1177/08980101251376863

RethinkTHC

RethinkTHC Research Database. "Improving Awareness and Use of Medical Cannabis for Fibromya..." RTHC-07098. Retrieved from https://rethinkthc.com/research/mcclure-2025-improving-awareness-and-use

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.